Literature DB >> 19094117

Induction of autoimmune cholangitis in non-obese diabetic (NOD).1101 mice following a chemical xenobiotic immunization.

K Wakabayashi1, K Yoshida, P S C Leung, Y Moritoki, G-X Yang, K Tsuneyama, Z-X Lian, T Hibi, A A Ansari, L S Wicker, W M Ridgway, R L Coppel, I R Mackay, M E Gershwin.   

Abstract

Our laboratory has suggested that loss of tolerance to pyruvate dehydrogenase (PDC-E2) leads to an anti-mitochondrial antibody response and autoimmune cholangitis, similar to human primary biliary cirrhosis (PBC). We have suggested that this loss of tolerance can be induced either via chemical xenobiotic immunization or exposure to select bacteria. Our work has also highlighted the importance of genetic susceptibility. Using the non-obese diabetic (NOD) congenic strain 1101 (hereafter referred to as NOD.1101 mice), which has chromosome 3 regions from B6 introgressed onto a NOD background, we exposed animals to 2-octynoic acid (2OA) coupled to bovine serum albumin (BSA). 2OA has been demonstrated previously by a quantitative structural activity relationship to react as well as or better than lipoic acid to anti-mitochondrial antibodies. We demonstrate herein that NOD.1101 mice immunized with 2OA-BSA, but not with BSA alone, develop high titre anti-mitochondrial antibodies and histological features, including portal infiltrates enriched in CD8(+) cells and liver granulomas, similar to human PBC. We believe this model will allow the rigorous dissection of early immunogenetic cause of biliary damage.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19094117      PMCID: PMC2669535          DOI: 10.1111/j.1365-2249.2008.03837.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  51 in total

1.  Myeloperoxidase-positive inflammatory cells participate in bile duct damage in primary biliary cirrhosis through nitric oxide-mediated reactions.

Authors:  Chih-Te Wu; Jason P Eiserich; Aftab A Ansari; Ross L Coppel; Sripriya Balasubramanian; Christopher L Bowlus; M Eric Gershwin; Judy Van De Water
Journal:  Hepatology       Date:  2003-10       Impact factor: 17.425

2.  Xenobiotic-induced loss of tolerance in rabbits to the mitochondrial autoantigen of primary biliary cirrhosis is reversible.

Authors:  Katsushi Amano; Patrick S C Leung; Qingchai Xu; Jan Marik; Chao Quan; Mark J Kurth; Michael H Nantz; Aftab A Ansari; Kit S Lam; Mikio Zeniya; Ross L Coppel; M Eric Gershwin
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

3.  Cytokine profile in the liver of primary biliary cirrhosis.

Authors:  T Nagano; K Yamamoto; S Matsumoto; R Okamoto; M Tagashira; N Ibuki; S Matsumura; K Yabushita; N Okano; T Tsuji
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

Review 4.  The consequences of apoptosis in autoimmunity.

Authors:  Ana Lleo; Carlo Selmi; Pietro Invernizzi; Mauro Podda; M Eric Gershwin
Journal:  J Autoimmun       Date:  2008-06-02       Impact factor: 7.094

5.  Monocyte chemotactic protein-1, -2, and -3 are distinctively expressed in portal tracts and granulomata in primary biliary cirrhosis: implications for pathogenesis.

Authors:  K Tsuneyama; K Harada; M Yasoshima; K Hiramatsu; C R Mackay; I R Mackay; M E Gershwin; Y Nakanuma
Journal:  J Pathol       Date:  2001-01       Impact factor: 7.996

6.  Th1 to Th2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation.

Authors:  D V Serreze; H D Chapman; C M Post; E A Johnson; W L Suarez-Pinzon; A Rabinovitch
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

7.  Incomplete Freund's adjuvant reduces diabetes in the non-obese diabetic mouse.

Authors:  R Liddi; P E Beales; G Rosignoli; P Pozzilli
Journal:  Horm Metab Res       Date:  2000-06       Impact factor: 2.936

8.  Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis.

Authors:  S A Long; C Quan; J Van de Water; M H Nantz; M J Kurth; D Barsky; M E Colvin; K S Lam; R L Coppel; A Ansari; M E Gershwin
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

9.  Immunization with a xenobiotic 6-bromohexanoate bovine serum albumin conjugate induces antimitochondrial antibodies.

Authors:  Patrick S C Leung; Chao Quan; Ogyi Park; Judy Van de Water; Mark J Kurth; Michael H Nantz; Aftab A Ansari; Ross L Coppel; Kit S Lam; M Eric Gershwin
Journal:  J Immunol       Date:  2003-05-15       Impact factor: 5.422

10.  Genetic control of autoimmunity: protection from diabetes, but spontaneous autoimmune biliary disease in a nonobese diabetic congenic strain.

Authors:  Syuichi Koarada; Yuehong Wu; Noreen Fertig; David A Sass; Michael Nalesnik; John A Todd; Paul A Lyons; Judith Fenyk-Melody; Daniel B Rainbow; Linda S Wicker; Laurence B Peterson; William M Ridgway
Journal:  J Immunol       Date:  2004-08-15       Impact factor: 5.422

View more
  34 in total

1.  B cell depletion therapy exacerbates murine primary biliary cirrhosis.

Authors:  Amy Dhirapong; Ana Lleo; Guo-Xiang Yang; Koichi Tsuneyama; Robert Dunn; Marilyn Kehry; Thomas A Packard; John C Cambier; Fu-Tong Liu; Keith Lindor; Ross L Coppel; Aftab A Ansari; M Eric Gershwin
Journal:  Hepatology       Date:  2010-12-28       Impact factor: 17.425

Review 2.  Primary biliary cirrhosis: From bench to bedside.

Authors:  Elias Kouroumalis; George Notas
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-08-06

3.  Etiopathogenesis of primary biliary cirrhosis: an overview of recent developments.

Authors:  Palak J Trivedi; Sue Cullen
Journal:  Hepatol Int       Date:  2012-03-20       Impact factor: 6.047

4.  Therapeutic effect of cytotoxic T lymphocyte antigen 4/immunoglobulin on a murine model of primary biliary cirrhosis.

Authors:  Amy Dhirapong; Guo-Xiang Yang; Steven Nadler; Weici Zhang; Koichi Tsuneyama; Patrick Leung; Stuart Knechtle; Aftab A Ansari; Ross L Coppel; Fu-Tong Liu; Xiao-Song He; M Eric Gershwin
Journal:  Hepatology       Date:  2013-02       Impact factor: 17.425

Review 5.  Xenobiotics and loss of tolerance in primary biliary cholangitis.

Authors:  Jinjun Wang; Guoxiang Yang; Alana Mari Dubrovsky; Jinjung Choi; Patrick S C Leung
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

6.  The induction of autoimmune hepatitis in the human leucocyte antigen-DR4 non-obese diabetic mice autoimmune hepatitis mouse model.

Authors:  M Yuksel; X Xiao; N Tai; Manakkat Vijay; E Gülden; K Beland; P Lapierre; F Alvarez; Z Hu; I Colle; Y Ma; L Wen
Journal:  Clin Exp Immunol       Date:  2016-08-23       Impact factor: 4.330

Review 7.  A contemporary perspective on the molecular characteristics of mitochondrial autoantigens and diagnosis in primary biliary cholangitis.

Authors:  Patrick S C Leung; Jinjung Choi; Guoxiang Yang; Elena Woo; Thomas P Kenny; M Eric Gershwin
Journal:  Expert Rev Mol Diagn       Date:  2016-03-30       Impact factor: 5.225

8.  Epigenetics in the Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.

Authors:  Angela C Cheung; Nicholas F LaRusso; Gregory J Gores; Konstantinos N Lazaridis
Journal:  Semin Liver Dis       Date:  2017-05-31       Impact factor: 6.115

Review 9.  The genetics of complex cholestatic disorders.

Authors:  Gideon M Hirschfield; Roger W Chapman; Tom H Karlsen; Frank Lammert; Konstantinos N Lazaridis; Andrew L Mason
Journal:  Gastroenterology       Date:  2013-04-10       Impact factor: 22.682

Review 10.  Animal models in primary biliary cirrhosis and primary sclerosing cholangitis.

Authors:  Marion J Pollheimer; Peter Fickert
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.